Pfizer forecast 2025 revenue and earnings in line with market expectations, despite a $1 billion hit from the redesign of federal drug benefits.
Related Posts
Kuehne + Nagel Earnings Boosted by Volume Growth and Efficiencies
Kuehne + Nagel reported a forecast-beating rise in third-quarter profitability as efficiency measures and higher volumes helped boost the performance of its sea and air […]
Mitsubishi UFJ’s Quarterly Profit Falls on Higher Credit Costs
The Japanese financial company reported a decline in its first-quarter net profit, partly due to higher credit costs.
Universal Music Sheds $16 Billion in Market Cap After Revenues Disappoint
The record label behind Taylor Swift, Billie Eilish and Ariana Grande posted revenue growth from subscriptions and streaming services well below what analysts had expected.